Novo Nordisk AS
A3EU6F
DK0062498333 //
Quelle: CPH Equities: 17:07:31
260,40 DKK
Kurs
Kurs
1,24%
Diff. Vortag in %
Diff. Vortag in %
224,25 DKK
52 Wochen Tief
52 Wochen Tief
533,40 DKK
52 Wochen Hoch
52 Wochen Hoch
- Eher Negativ
- Seit dem 27.03.2026
- Informationen von thescreener.com
Tools
Fundamentalanalyse
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 15.04.2026 12 Monate | 15.04.2026 | 12 Monate | 260,40 270 | 260,40 | 270 | 3,686636 | JEFFERIES | ||
| Novo Nordisk AS | 09.04.2026 0 Monate | 09.04.2026 | 0 Monate | 260,40 332 | 260,40 | 332 | 27,49616 | UBS | ||
| Novo Nordisk AS | 01.04.2026 0 Monate | 01.04.2026 | 0 Monate | 260,40 270 | 260,40 | 270 | 3,686636 | BARCLAYS | ||
| Novo Nordisk AS | 31.03.2026 12 Monate | 31.03.2026 | 12 Monate | 260,40 263 | 260,40 | 263 | 0,998464 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 30.03.2026 0 Monate | 30.03.2026 | 0 Monate | 260,40 270 | 260,40 | 270 | 3,686636 | BARCLAYS | ||
| Novo Nordisk AS | 29.03.2026 0 Monate | 29.03.2026 | 0 Monate | 260,40 250 | 260,40 | 250 | 3,993856 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 260,40 275 | 260,40 | 275 | 5,606759 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.03.2026 0 Monate | 26.03.2026 | 0 Monate | 260,40 270 | 260,40 | 270 | 3,686636 | BARCLAYS | ||
| Novo Nordisk AS | 25.03.2026 0 Monate | 25.03.2026 | 0 Monate | 260,40 250 | 260,40 | 250 | 3,993856 | JPMORGAN | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 260,40 270 | 260,40 | 270 | 3,686636 | JEFFERIES | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 260,40 270 | 260,40 | 270 | 3,686636 | BARCLAYS | ||
| Novo Nordisk AS | 11.03.2026 0 Monate | 11.03.2026 | 0 Monate | 260,40 300 | 260,40 | 300 | 15,207373 | BERENBERG |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 09.03.2026 0 Monate | 09.03.2026 | 0 Monate | 260,40 250 | 260,40 | 250 | 3,993856 | JPMORGAN | ||
| Novo Nordisk AS | 06.03.2026 12 Monate | 06.03.2026 | 12 Monate | 260,40 270 | 260,40 | 270 | 3,686636 | BARCLAYS | ||
| Novo Nordisk AS | 02.03.2026 12 Monate | 02.03.2026 | 12 Monate | 260,40 260 | 260,40 | 260 | 0,15361 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 02.03.2026 0 Monate | 02.03.2026 | 0 Monate | 260,40 270 | 260,40 | 270 | 3,686636 | BARCLAYS | ||
| Novo Nordisk AS | 27.02.2026 12 Monate | 27.02.2026 | 12 Monate | 260,40 270 | 260,40 | 270 | 3,686636 | BARCLAYS | ||
| Novo Nordisk AS | 24.02.2026 12 Monate | 24.02.2026 | 12 Monate | 260,40 400 | 260,40 | 400 | 53,609831 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.02.2026 0 Monate | 24.02.2026 | 0 Monate | 260,40 250 | 260,40 | 250 | 3,993856 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 260,40 400 | 260,40 | 400 | 53,609831 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 260,40 332 | 260,40 | 332 | 27,49616 | UBS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 260,40 340 | 260,40 | 340 | 30,568356 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 260,40 275 | 260,40 | 275 | 5,606759 | JEFFERIES | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 260,40 350 | 260,40 | 350 | 34,408602 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 260,40 340 | 260,40 | 340 | 30,568356 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 260,40 275 | 260,40 | 275 | 5,606759 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 260,40 250 | 260,40 | 250 | 3,993856 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 260,40 270 | 260,40 | 270 | 3,686636 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 260,40 340 | 260,40 | 340 | 30,568356 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 260,40 340 | 260,40 | 340 | 30,568356 | BARCLAYS | ||
| Novo Nordisk AS | 17.02.2026 0 Monate | 17.02.2026 | 0 Monate | 260,40 340 | 260,40 | 340 | 30,568356 | BARCLAYS | ||
| Novo Nordisk AS | 12.02.2026 0 Monate | 12.02.2026 | 0 Monate | 260,40 340 | 260,40 | 340 | 30,568356 | BARCLAYS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 260,40 400 | 260,40 | 400 | 53,609831 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 260,40 275 | 260,40 | 275 | 5,606759 | JEFFERIES | ||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 260,40 360 | 260,40 | 360 | 38,248848 | BERENBERG | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 260,40 360 | 260,40 | 360 | 38,248848 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 260,40 360 | 260,40 | 360 | 38,248848 | BARCLAYS | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 260,40 350 | 260,40 | 350 | 34,408602 | JPMORGAN | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 260,40 332 | 260,40 | 332 | 27,49616 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 260,40 475 | 260,40 | 475 | 82,411674 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 260,40 332 | 260,40 | 332 | 27,49616 | UBS | ||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 260,40 350 | 260,40 | 350 | 34,408602 | JPMORGAN | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 260,40 270 | 260,40 | 270 | 3,686636 | JEFFERIES | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 260,40 350 | 260,40 | 350 | 34,408602 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 260,40 350 | 260,40 | 350 | 34,408602 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 260,40 360 | 260,40 | 360 | 38,248848 | BARCLAYS | ||
| Novo Nordisk AS | 01.02.2026 0 Monate | 01.02.2026 | 0 Monate | 260,40 390 | 260,40 | 390 | 49,769585 | UBS | ||
| Novo Nordisk AS | 29.01.2026 0 Monate | 29.01.2026 | 0 Monate | 260,40 350 | 260,40 | 350 | 34,408602 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 23.01.2026 12 Monate | 23.01.2026 | 12 Monate | 260,40 270 | 260,40 | 270 | 3,686636 | JEFFERIES | ||
| Novo Nordisk AS | 22.01.2026 12 Monate | 22.01.2026 | 12 Monate | 260,40 436 | 260,40 | 436 | 67,434716 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 22.01.2026 0 Monate | 22.01.2026 | 0 Monate | 260,40 415 | 260,40 | 415 | 59,3702 | BERENBERG | ||
| Novo Nordisk AS | 21.01.2026 12 Monate | 21.01.2026 | 12 Monate | 260,40 360 | 260,40 | 360 | 38,248848 | BARCLAYS | ||
| Novo Nordisk AS | 20.01.2026 12 Monate | 20.01.2026 | 12 Monate | 260,40 270 | 260,40 | 270 | 3,686636 | JEFFERIES | ||
| Novo Nordisk AS | 20.01.2026 0 Monate | 20.01.2026 | 0 Monate | 260,40 390 | 260,40 | 390 | 49,769585 | UBS | ||
| Novo Nordisk AS | 19.01.2026 0 Monate | 19.01.2026 | 0 Monate | 260,40 390 | 260,40 | 390 | 49,769585 | UBS | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 260,40 360 | 260,40 | 360 | 38,248848 | BARCLAYS | ||
| Novo Nordisk AS | 15.01.2026 0 Monate | 15.01.2026 | 0 Monate | 260,40 415 | 260,40 | 415 | 59,3702 | BERENBERG | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 260,40 475 | 260,40 | 475 | 82,411674 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 260,40 350 | 260,40 | 350 | 34,408602 | JPMORGAN | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 260,40 390 | 260,40 | 390 | 49,769585 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 09.01.2026 12 Monate | 09.01.2026 | 12 Monate | 260,40 400 | 260,40 | 400 | 53,609831 | BERENBERG | ||
| Novo Nordisk AS | 07.01.2026 12 Monate | 07.01.2026 | 12 Monate | 260,40 400 | 260,40 | 400 | 53,609831 | BERENBERG | ||
| Novo Nordisk AS | 06.01.2026 12 Monate | 06.01.2026 | 12 Monate | 260,40 360 | 260,40 | 360 | 38,248848 | BARCLAYS | ||
| Novo Nordisk AS | 02.01.2026 0 Monate | 02.01.2026 | 0 Monate | 260,40 350 | 260,40 | 350 | 34,408602 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 260,40 475 | 260,40 | 475 | 82,411674 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 16.12.2025 12 Monate | 16.12.2025 | 12 Monate | 260,40 350 | 260,40 | 350 | 34,408602 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 260,40 475 | 260,40 | 475 | 82,411674 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 12.12.2025 0 Monate | 12.12.2025 | 0 Monate | 260,40 295 | 260,40 | 295 | 13,28725 | UBS | ||
| Novo Nordisk AS | 11.12.2025 0 Monate | 11.12.2025 | 0 Monate | 260,40 295 | 260,40 | 295 | 13,28725 | UBS | ||
| Novo Nordisk AS | 08.12.2025 12 Monate | 08.12.2025 | 12 Monate | 260,40 350 | 260,40 | 350 | 34,408602 | JPMORGAN | ||
| Novo Nordisk AS | 08.12.2025 12 Monate | 08.12.2025 | 12 Monate | 260,40 352 | 260,40 | 352 | 35,176651 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 04.12.2025 0 Monate | 04.12.2025 | 0 Monate | 260,40 400 | 260,40 | 400 | 53,609831 | BERENBERG |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 03.12.2025 0 Monate | 03.12.2025 | 0 Monate | 260,40 295 | 260,40 | 295 | 13,28725 | UBS | ||
| Novo Nordisk AS | 30.11.2025 0 Monate | 30.11.2025 | 0 Monate | 260,40 270 | 260,40 | 270 | 3,686636 | JEFFERIES | ||
| Novo Nordisk AS | 28.11.2025 12 Monate | 28.11.2025 | 12 Monate | 260,40 375 | 260,40 | 375 | 44,009217 | BARCLAYS | ||
| Novo Nordisk AS | 28.11.2025 0 Monate | 28.11.2025 | 0 Monate | 260,40 315 | 260,40 | 315 | 20,967742 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 260,40 475 | 260,40 | 475 | 82,411674 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.11.2025 12 Monate | 26.11.2025 | 12 Monate | 260,40 353 | 260,40 | 353 | 35,560676 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 260,40 475 | 260,40 | 475 | 82,411674 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 25.11.2025 0 Monate | 25.11.2025 | 0 Monate | 260,40 500 | 260,40 | 500 | 92,012289 | JPMORGAN | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 260,40 500 | 260,40 | 500 | 92,012289 | JPMORGAN | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 260,40 290 | 260,40 | 290 | 11,367127 | JEFFERIES | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 260,40 375 | 260,40 | 375 | 44,009217 | BARCLAYS | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 260,40 391 | 260,40 | 391 | 50,15361 | GOLDMAN SACHS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 24.11.2025 0 Monate | 24.11.2025 | 0 Monate | 260,40 | 260,40 | -- | DZ BANK | |||
| Novo Nordisk AS | 17.11.2025 0 Monate | 17.11.2025 | 0 Monate | 260,40 315 | 260,40 | 315 | 20,967742 | UBS | ||
| Novo Nordisk AS | 13.11.2025 0 Monate | 13.11.2025 | 0 Monate | 260,40 400 | 260,40 | 400 | 53,609831 | BERENBERG | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 260,40 475 | 260,40 | 475 | 82,411674 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 10.11.2025 12 Monate | 10.11.2025 | 12 Monate | 260,40 600 | 260,40 | 600 | 130,414747 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 10.11.2025 12 Monate | 10.11.2025 | 12 Monate | 260,40 | 260,40 | -- | DZ BANK | |||
| Novo Nordisk AS | 10.11.2025 0 Monate | 10.11.2025 | 0 Monate | 260,40 315 | 260,40 | 315 | 20,967742 | UBS | ||
| Novo Nordisk AS | 07.11.2025 0 Monate | 07.11.2025 | 0 Monate | 260,40 315 | 260,40 | 315 | 20,967742 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 260,40 600 | 260,40 | 600 | 130,414747 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 260,40 391 | 260,40 | 391 | 50,15361 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.11.2025 0 Monate | 06.11.2025 | 0 Monate | 260,40 540 | 260,40 | 540 | 107,373272 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 260,40 290 | 260,40 | 290 | 11,367127 | JEFFERIES |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 260,40 500 | 260,40 | 500 | 92,012289 | JPMORGAN | ||
| Novo Nordisk AS | 05.11.2025 12 Monate | 05.11.2025 | 12 Monate | 260,40 500 | 260,40 | 500 | 92,012289 | JPMORGAN | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 260,40 290 | 260,40 | 290 | 11,367127 | JEFFERIES | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 260,40 340 | 260,40 | 340 | 30,568356 | UBS |
News
Aktuell
| Datum | Terminart Information | Information |
|---|---|---|
| 06.05.2026 | Bericht zum 1. Quartal Novo Nordisk A/S: First quarter 2026 | Novo Nordisk A/S: First quarter 2026 |
| 05.08.2026 | Bericht zum 2. Quartal Novo Nordisk A/S: Second quarter 2026 | Novo Nordisk A/S: Second quarter 2026 |
DZ BANK Produktauswahl
Discount Classic
Produktauswahl : Basiswert Novo Nordisk AS
Min
Discount in %
Max
Endlos Turbos Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Optionsscheine Classic Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
Abstand zum Basispreis in %
Max
Endlos Turbos Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Mini-Futures Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Knock Out Map
- wertpapiere@dzbank.de (069) 7447-7035
-
DZ BANK AG, Platz der Republik,
60265 Frankfurt / M